Back to Journals » Journal of Pain Research » Volume 14

Long Noncoding RNA H19 Induces Neuropathic Pain by Upregulating Cyclin-Dependent Kinase 5-Mediated Phosphorylation of cAMP Response Element Binding Protein [Retraction]

Authors Li K, Jiao Y, Ren X, You D, Cao R

Received 27 July 2021

Accepted for publication 27 July 2021

Published 30 July 2021 Volume 2021:14 Pages 2335—2336

DOI https://doi.org/10.2147/JPR.S331373



Li K, Jiao Y, Ren X, You D, Cao R. J Pain Res. 2020;13:2113–2124.

At the request of the authors, the Editor-in-chief and Publisher of Journal of Pain Research wish to retract the following article.

In the reported study the authors found that Long noncoding RNA H19 was highly expressed in the spinal dorsal horn after chronic constriction injury in rats, and the silencing of H19 could ameliorate neuropathic pain via the von Frey filament test. Recently, the authors performed another batch of experiments using the same neuropathic pain model, and knockdown of H19 by siRNA served as a positive control, which was supposed to inhibit neuropathic pain. However, the authors found that the silencing of H19 by the siRNA did not ameliorate the neuropathic pain and despite several attempts the behavioral test previously described could not be reproduced and the authors cannot clearly explain the reason for this. As they are unable to support their findings the authors wish to retract the published paper and the editor has agreed with this request.

Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.

This retraction relates to this paper

Creative Commons License © 2021 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.